Epstein-Barr-virus-specific functional antibody signatures in the context of nasopharyngeal carcinoma development.

Saved in:
Bibliographic Details
Title: Epstein-Barr-virus-specific functional antibody signatures in the context of nasopharyngeal carcinoma development.
Authors: Roy V; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA; Institute of Virology, University Hospital Bonn, Bonn, Germany., Kellman BP; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA., Hsu WL; Data Science Center, College of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan; Master Program of Big Data Analysis in Biomedicine, College of Medicine, Fu-Jen Catholic University, New Taipei City, Taiwan., Nziza N; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA., Parker L; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA., Germosen D; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA., Bonifer R; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA., Pfeiffer RM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Yu KJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Michels B; Division of Infections and Cancer Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany., Chen TC; Department of Otolaryngology, National Taiwan University Hospital and National Taiwan University, College of Medicine, Taipei, Taiwan., Chen CJ; Genomics Research Center, Academia Sinica, Taipei, Taiwan., Goldstein AM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Waterboer T; Division of Infections and Cancer Epidemiology, German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), Heidelberg, Germany., Wang CP; Department of Otolaryngology, National Taiwan University Hospital and National Taiwan University, College of Medicine, Taipei, Taiwan., Kumar N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Jain A; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore, Singapore., Newell EW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Streeck H; Institute of Virology, University Hospital Bonn, Bonn, Germany., Alter G; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA., Hildesheim A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA; Agencia Costarriciense de Investigaciones Biologicas, San Jose, Costa Rica., Liu Z; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. Electronic address: liuzhiwei1125@gmail.com., Julg B; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA. Electronic address: bjulg@mgh.harvard.edu.
Source: Med (New York, N.Y.) [Med] 2026 Jan 09; Vol. 7 (1), pp. 100925. Date of Electronic Publication: 2025 Nov 18.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101769215 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6340 (Electronic) Linking ISSN: 26666340 NLM ISO Abbreviation: Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-6340
DOI:10.1016/j.medj.2025.100925